The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary safety and efficacy of evofosfamide (TH-302), an investigational hypoxia-activated prodrug, combined with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma (RR MM).
 
Jacob Laubach
Research Funding - Celgene; Millennium; Novartis; Onyx
 
Noopur S. Raje
Honoraria - Amgen; Celgene; Millennium; Onyx
Research Funding - Acetylon Pharmaceuticals; Lilly
 
Andrew Jenho Yee
No Relationships to Disclose
 
Philippe Armand
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; Merck; Otsuka; Sequenta; Sigma-Tau
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Sequenta
 
Robert L. Schlossman
No Relationships to Disclose
 
Jacalyn Rosenblatt
No Relationships to Disclose
 
Jacquelyn Ann Hedlund
No Relationships to Disclose
 
Michael Gary Martin
No Relationships to Disclose
 
Craig H. Reynolds
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Boehringer Ingelheim; Celgene; Genentech; Lilly
Consulting or Advisory Role - Boehringer Ingelheim; Genentech
Speakers' Bureau - Boehringer Ingelheim; Celgene; Genentech; Lilly
Travel, Accommodations, Expenses - Lilly
 
Kenneth H. Shain
No Relationships to Disclose
 
Ira Zackon
No Relationships to Disclose
 
Laura Stampleman
No Relationships to Disclose
 
Erica Boswell
No Relationships to Disclose
 
Stacey Chuma
No Relationships to Disclose
 
Rebecca Liguori
No Relationships to Disclose
 
Damian Handisides
Employment - Threshold Pharmaceuticals
Stock and Other Ownership Interests - Threshold Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Threshold Pharmaceuticals
Travel, Accommodations, Expenses - Threshold Pharmaceuticals
 
Stew Kroll
Employment - Threshold Pharmaceuticals
Stock and Other Ownership Interests - Threshold Pharmaceuticals
Travel, Accommodations, Expenses - Threshold Pharmaceuticals
 
Kenneth Carl Anderson
Stock and Other Ownership Interests - Acetylon Pharmaceuticals; OncoPep
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Millennium; Sanofi
 
Paul G. Richardson
Consulting or Advisory Role - Johnson & Johnson; Takeda; Threshold Pharmaceuticals
 
Irene M. Ghobrial
No Relationships to Disclose